Schlereth Tanja, Mouka Irini, Eisenbarth Gabi, Winterholler Martin, Birklein Frank
Department of Neurology, University of Mainz, Germany.
Auton Neurosci. 2005 Feb 7;117(2):120-6. doi: 10.1016/j.autneu.2004.11.005.
Botulinum toxin type A (BoNT/A) is 20-50 times more effective than Botulinum toxin type B (BoNT/B) concerning the treatment of muscular hypercontractions [Sloop, R.R., Cole, B.A., Escutin, R.O., 1997. Human response to botulinum toxin injection: type B compared with type A. Neurology 49, 189-194]. Botulinum toxins block motor nerves as well as autonomic fibres [Rand, M.J., Whaler, B.C., 1965. Impairment of sympathetic transmission by botulinum toxin. Nature 206, 588-591].
Purpose of this study was to analyse the dose dependent reduction of sweating using the BoNT/A preparation Botox and to compare the results with our earlier results analysing Dysport [Braune, C., Erbguth, F., Birklein, F., 2001. Dose thresholds and duration of the local anhidrotic effect of botulinum toxin injections: measured by sudometry. Br. J. Dermatol. 144, 111-117] and Neurobloc (BoNT/B) [Birklein, F., Eisenbarth, G., Erbguth, F., Winterholler, M., 2003. Botulinum toxin type B blocks sudomotor function effectively: a 6 month follow up. J. Invest. Dermatol. 121, 1312-1316].
Different doses of Botox were injected subcutaneously (n=27 healthy subjects). Planimetrical analyses of the area of anhidrosis and quantitative sudomotor-axon-reflex testing (QSART) were done after 3 weeks, 3 and 6 months.
A threshold dose of 1.25 MU Botox led to anhidrotic skin spots after 3 weeks. The duration of anhidrosis was prolonged for 3 months when 17.5 MU and for 6 months when 50 MU were injected. Anhidrotic area size decreased with time (p=0.001), indicating partial recovery at the edges. After 3 weeks, QSART had significantly decreased to 29% of baseline. With doses of 70 MU or more it decreased to zero. After 3 months, QSART had returned to 68% of baseline and after 6 months to 87%.
Botox dose-dependently suppressed sweating. Comparison to Dysport and Neurobloc revealed a strikingly similar efficacy after 3 weeks and 3 months for all preparations. BoNT/A in general induced a more sustained anhidrosis than BoNT/B.
在治疗肌肉过度收缩方面,A型肉毒毒素(BoNT/A)的效果比B型肉毒毒素(BoNT/B)强20至50倍[Sloop, R.R., Cole, B.A., Escutin, R.O., 1997. 人类对肉毒毒素注射的反应:B型与A型的比较。《神经病学》49, 189 - 194]。肉毒毒素可阻断运动神经以及自主神经纤维[Rand, M.J., Whaler, B.C., 1965. 肉毒毒素对交感神经传递的损害。《自然》206, 588 - 591]。
本研究的目的是分析使用A型肉毒毒素制剂保妥适(Botox)时出汗量的剂量依赖性减少情况,并将结果与我们早期分析Dysport[Braune, C., Erbguth, F., Birklein, F., 2001. 肉毒毒素注射的局部止汗效果的剂量阈值和持续时间:通过汗液测量法测量。《英国皮肤病学杂志》144, 111 - 117]和Neurobloc(B型肉毒毒素)[Birklein, F., Eisenbarth, G., Erbguth, F., Winterholler, M., 2003. B型肉毒毒素有效阻断汗腺运动功能:6个月随访。《皮肤病学研究杂志》121, 1312 - 1316]的结果进行比较。
对27名健康受试者皮下注射不同剂量的保妥适。在3周、3个月和6个月后,对无汗区域进行平面测量分析,并进行定量汗腺运动轴突反射测试(QSART)。
1.25 MU保妥适的阈值剂量在3周后导致出现无汗皮肤斑。注射17.5 MU时无汗持续时间延长3个月,注射50 MU时延长6个月。无汗区域大小随时间减小(p = 0.001),表明边缘部位有部分恢复。3周后,QSART显著降至基线的29%。剂量达到70 MU或更高时降至零。3个月后,QSART恢复到基线的68%,6个月后恢复到87%。
保妥适剂量依赖性地抑制出汗。与Dysport和Neurobloc比较显示,在3周和3个月时,所有制剂的疗效惊人地相似。一般来说,A型肉毒毒素比B型肉毒毒素诱导的无汗持续时间更长。